Efficacy of glucagon-like peptide-1 receptor agonists and its application in bariatric and meta-bolic surgery

VernacularTitle:胰高血糖素样肽-1受体激动剂类药物疗效及在减重代谢外科中的应用
Author: Cunchuan WANG ¹ ; Qingyang MA ; Wenhui CHEN
Author Information

1. 暨南大学附属第一医院肥胖与代谢病外科，广州　510630
Keywords: Obesity; Bariatric metabolic surgery; Weight-loss drugs; Glucagon-like peptide-1 receptor agonist; Application
From: Chinese Journal of Digestive Surgery 2024;23(8):1022-1028
CountryChina
Language:Chinese
Abstract: At present, the prevalence of overweight and obesity is increasing rapidly. Baria-tric and metabolic surgery is an effective means to treat obesity and related comorbidities, but only a few obesity patients have received bariatric surgery, and most patients choose to accept drugs to lose weight. Glucagon-like peptide-1 receptor agonists (GLP-1RA), as an emerging drug, has a signi-ficant effect on overweight and obesity patients, and can be used as a beneficial supplement for bariatric surgery, which has a profound impact on bariatric surgery. Based on the relevant literature, the authors discuss the application and influence of GLP-1RA in bariatric and metabolic surgery.